Ex parte BAUM et al. - Page 5




          Appeal No. 1997-2671                                                        
          Application No. 08/446,473                                                  

          such a mole ratio within the here claimed range for the                     
          reasons discussed above.                                                    
               In essence, the compositions disclosed by Lokkesmoe for                
          use in his method appear to be identical to compositions                    
          encompassed by the here claimed method, and thus it is                      
          appropriate to require the appellants to prove that patentee’s              
          compositions do not necessarily or inherently possess the                   
          characteristics of their claimed composition including the                  
          appealed claim 1 mole ratio of acetic acid to peroxyacetic                  
          acid at equilibrium.  Whether the rejection is based on                     
          “inherency” under 35 U.S.C. 102, on “prima facie obviousness”               
          under 35 U.S.C. 103, jointly or alternatively, the burden of                
          proof is the same, and its fairness is evidenced by the                     
          inability of the Patent and Trademark Office to manufacture                 
          products or to obtain and compare prior art products.  In re                
          Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433-434 (CCPA 1977).               
               In addition to the foregoing, we agree with the                        
          examiner’s conclusion that it would have been obvious for an                
          artisan with ordinary skill to determine workable or even                   
          optimum ranges for the mole ratio parameters discussed above.               
          This is because such parameters are quite plainly result                    

                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007